| MEB MEB Outsources Psychology Services in support of ilumen |
| 14/03/19 | PRICE SENSITIVE | | Share |
|
| MEB Entitlement Issue Results and Shortfall Notification |
| 12/03/19 | PRICE SENSITIVE | | Share |
|
| MEB Ilumen Successfully Completes First Commercial Program |
| 07/03/19 | PRICE SENSITIVE | | Share |
|
| MEB Half Yearly Report and Accounts |
| 28/02/19 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Quarterly Update and Cashflow Report |
| 31/01/19 | PRICE SENSITIVE | | Share |
|
| MEB Entitlement Offer Booklet |
| 18/12/18 | PRICE SENSITIVE | | Share |
|
| MEB Converting Note & Non-Renounceable Entitlement Offer |
| 10/12/18 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 06/12/18 | PRICE SENSITIVE | | Share |
|
| MEB Pause in Trading |
| 06/12/18 | PRICE SENSITIVE | | Share |
|
| MEB Exclusive Agreement Signed for ilumen Pilot Program |
| 27/11/18 | PRICE SENSITIVE | | Share |
|
| MEB Response to ASX Appendix 4C Query |
| 15/11/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Provides Update on FDA Process |
| 09/11/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Appoints CEO and Managing Director |
| 02/11/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Market Update |
| 02/11/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Quarterly Update and Cashflow Report |
| 30/10/18 | PRICE SENSITIVE | | Share |
|
| MEB MEB Signs ilumen Contract with Large Australian Employer |
| 24/10/18 | PRICE SENSITIVE | | Share |
|
| MEB Receipt of R&D Tax Incentive Refund |
| 15/10/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Releases Corporate Health Product, ilumen |
| 03/10/18 | PRICE SENSITIVE | | Share |
|
| MEB Notice Received Under Section 249D of the Corporations Act |
| 01/10/18 | PRICE SENSITIVE | | Share |
|
| MEB Executive Leadership Changes |
| 21/09/18 | PRICE SENSITIVE | | Share |
|
| MEB Clinical Study Shows Improvement to Diagnostic Standard |
| 06/09/18 | PRICE SENSITIVE | | Share |
|
| MEB Preliminary Final Report |
| 30/08/18 | PRICE SENSITIVE | | Share |
|
| MEB Departure of Managing Director & Chief Executive Officer |
| 29/08/18 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 28/08/18 | PRICE SENSITIVE | | Share |
|
| MEB Pause in Trading |
| 28/08/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Quarterly Update and Cashflow Report |
| 31/07/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Submits FDA De Novo Application |
| 16/07/18 | PRICE SENSITIVE | 104.57KB | Share |
|
| MEB Medibio Receives TGA Approval |
| 19/06/18 | PRICE SENSITIVE | 131.54KB | Share |
|
| MEB MEB Signs Global Contract with Jacobs Engineering |
| 25/05/18 | PRICE SENSITIVE | 203.19KB | Share |
|
| MEB Medibio Announces Next Tranche of Corporate Health Contracts |
| 10/05/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Signs First Corporate Health Contract |
| 09/05/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Receives CE Certification |
| 03/05/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Quarterly Update and Cashflow Report |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| MEB MEB signs binding term sheet to acquire Vital Conversations |
| 05/03/18 | PRICE SENSITIVE | | Share |
|
| MEB Half Yearly Report and Accounts |
| 27/02/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Quarterly Update and Cash Flow Report |
| 31/01/18 | PRICE SENSITIVE | | Share |
|
| MEB Agreement with Striiv to Accelerate Commercialisation |
| 22/01/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Announces ISO 13485 Certification |
| 10/01/18 | PRICE SENSITIVE | | Share |
|
| MEB Medibio & Mayo Clinic collaborate on depression technology |
| 14/12/17 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly |
| 30/10/17 | PRICE SENSITIVE | | Share |
|
| MEB MEB completes heavily oversubscribed institutional placement |
| 13/10/17 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 11/10/17 | PRICE SENSITIVE | | Share |
|
| MEB Response to ASX Query |
| 11/10/17 | PRICE SENSITIVE | | Share |
|
| MEB Medibio enters into an Agreement with Otsuka Pharmaceutical |
| 09/10/17 | PRICE SENSITIVE | | Share |
|
| MEB Medibio enters agreement with Mayo Clinc |
| 04/10/17 | PRICE SENSITIVE | | Share |
|
| MEB Preliminary Final Report |
| 01/09/17 | PRICE SENSITIVE | | Share |
|
| MEB Medibio initiates confirmatory study |
| 21/08/17 | PRICE SENSITIVE | | Share |
|
| MEB Medibio announces positive clinical study results |
| 02/08/17 | PRICE SENSITIVE | | Share |
|
| MEB Quarterly ASX Update and Cashflows |
| 27/07/17 | PRICE SENSITIVE | | Share |
|
| MEB Scientific breakthrough on objective diagnosis of PTSD |
| 26/06/17 | PRICE SENSITIVE | | Share |
|
| MEB Independent researchers present first data validating MEB |
| 08/06/17 | PRICE SENSITIVE | | Share |
|
| MEB Signed second agreement for Wellness |
| 17/05/17 | PRICE SENSITIVE | | Share |
|
| MEB MEB Signs Strategic Joint Development Agreement with Mayo Cl |
| 10/05/17 | PRICE SENSITIVE | | Share |
|
| MEB Quarterly ASX Update and Cashflow |
| 27/04/17 | PRICE SENSITIVE | | Share |
|
| MEB MEB enters fully funded Paediatric mental illness diagnostic |
| 10/04/17 | PRICE SENSITIVE | | Share |
|
| MEB Conversion of Options to Partly Paid shares |
| 05/04/17 | PRICE SENSITIVE | | Share |
|
| MEB Company Update |
| 20/03/17 | PRICE SENSITIVE | | Share |
|
| MEB Half Yearly Report and Accounts |
| 28/02/17 | PRICE SENSITIVE | | Share |
|
| MEB MEB appoints US med-tech veteran as CEO & Managing Director |
| 16/02/17 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly |
| 31/01/17 | PRICE SENSITIVE | | Share |
|
| MEB Early Redemption of Convertible Note |
| 30/01/17 | PRICE SENSITIVE | | Share |
|
| MEB Partnership with leading US University on PTSD |
| 25/01/17 | PRICE SENSITIVE | | Share |
|
| MEB Excellent performance in the pilot phase of US Validation |
| 21/12/16 | PRICE SENSITIVE | | Share |
|
| MEB Medibio enters into binding agreement with Medtronic |
| 24/11/16 | PRICE SENSITIVE | | Share |
|
| MEB Capital raising of $13.5million to accelerate growth |
| 18/11/16 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 15/11/16 | PRICE SENSITIVE | | Share |
|
| MEB Outstanding 86% accuracy in 889 person Ottawa Uni study-MEB.AX |
| 02/11/16 | PRICE SENSITIVE | | Share |
|
| MEB Quarterly Activities Report-MEB.AX |
| 31/10/16 | PRICE SENSITIVE | | Share |
|
| MEB Quarterly Cashflow Report-MEB.AX |
| 31/10/16 | PRICE SENSITIVE | | Share |
|
| MEB Receipt of $3,074,224 R & D Tax Incentive Refund-MEB.AX |
| 14/10/16 | PRICE SENSITIVE | | Share |
|
| MEB Partners with HBF and Vital Conversations on mental health-MEB.AX |
| 11/10/16 | PRICE SENSITIVE | | Share |
|
| MEB Funding Update-MEB.AX |
| 10/10/16 | PRICE SENSITIVE | | Share |
|
| MEB Medibio and Monash Groundbreaking partnership on innovation-MEB.AX |
| 14/09/16 | PRICE SENSITIVE | | Share |
|
| MEB Preliminary Final Report-MEB.AX |
| 31/08/16 | PRICE SENSITIVE | | Share |
|
| MEB Commercial Trial and Validation Update-MEB.AX |
| 17/08/16 | PRICE SENSITIVE | | Share |
|
| MEB Breakthrough validation of depression test with Ottawa Univ-MEB.AX |
| 08/08/16 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt-MEB.AX |
| 05/08/16 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly-MEB.AX |
| 01/08/16 | PRICE SENSITIVE | | Share |
|
| MEB MEB Advanced Analytics Cloud Solution breaks new ground in S-MEB.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| MEB MEB Advanced Analytics Cloud Solution breaks new ground in S-MEB.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| MEB Medibio's first commercial pilot study a success-MEB.AX |
| 30/05/16 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly & activities report-MEB.AX |
| 02/05/16 | PRICE SENSITIVE | | Share |
|
| MEB Medibio Acquires Key IP-MEB.AX |
| 19/04/16 | PRICE SENSITIVE | | Share |
|
| MEB Successful Pre-Submission Meeting with the US FDA |
| 01/04/16 | PRICE SENSITIVE | | Share |
|
| MEB 4 leading US Institutions provide Medibio 10,000 data sets |
| 11/03/16 | PRICE SENSITIVE | | Share |
|
| MEB Swinburne Software Labs trial success with Apple Watch & FIT |
| 08/03/16 | PRICE SENSITIVE | | Share |
|
| MEB Half Yearly Report and Accounts |
| 26/02/16 | PRICE SENSITIVE | | Share |
|
| MEB Partnership to evaluate wearable applications for Mental Hea |
| 09/02/16 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly |
| 01/02/16 | PRICE SENSITIVE | | Share |
|
| MEB Receipt of R&D Tax Incentive Refund |
| 14/01/16 | PRICE SENSITIVE | | Share |
|
| MEB MEB signs MOU with $100 billion NYSE listed medical company |
| 22/12/15 | PRICE SENSITIVE | | Share |
|
| MEB Johns Hopkins University Depression Study Update |
| 24/11/15 | PRICE SENSITIVE | | Share |
|
| MEB Medibio's corporate partner signs multinational customer |
| 06/11/15 | PRICE SENSITIVE | | Share |
|
| MEB Appendix 4C - quarterly |
| 30/10/15 | PRICE SENSITIVE | | Share |
|
| MEB Medebio collaborates with University of Ottawa on research |
| 12/10/15 | PRICE SENSITIVE | | Share |
|
| MEB Medibio signs second commercial agreement for Corporate Stre |
| 25/09/15 | PRICE SENSITIVE | | Share |
|
| MEB Capital raising of $3.1 million to accelerate growth |
| 02/09/15 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 31/08/15 | PRICE SENSITIVE | | Share |
|
| MEB Medibio signs first commercial agreement for its Corporate S |
| 27/08/15 | PRICE SENSITIVE | | Share |
|
| MEB Trading Halt |
| 25/08/15 | PRICE SENSITIVE | | Share |
|
